In the context of new anti-obesity medications, the American College of Cardiology has issued a Scientific Statement updating ...

with the label expanded in the US to include patients with heart failure with preserved ejection fraction (HFpEF) last month. It has been used to treat type 2 diabetes since 2014. So far ...

People with a complex heart, kidney and metabolic ... (no risk factors), stage 1 (excess weight), stage 2 (metabolic risk factors and kidney disease), stage 3 (subclinical cardiovascular disease ...

GPs will be able to start prescribing a wider range of treatments for early stage chronic heart failure under new draft guidance from the National Institute for Health and Care Excellence (NICE).1 ...